The Biosimilars & Biologics Summit 2023 is the only event of its kind to deliver leading market intelligence and industry presentations on the latest in biosimilars therapeutics, which can be interchangeable with biologics to reduce healthcare costs and chronic disease management.


Benefits of attending include:


  • Two days of in-depth presentations revealing the latest market intelligence addressing the diagnostic industry’s collective focus by sharing results and industry experiences.
  • Exclusive networking opportunity, a chance to engage with other professionals with shared challenges and experiences in this fast-developing sector.
  • Updates on regional projects and research led by leading biosimilars technology experts detailing their experiences, findings, and new proposals.
  • Technical presentations from biosimilars developers showcasing the latest results from recent tests and trials, technological developments, and new technical know-how.
  • New case studies on specific examples from leading industry experts in diagnostic development.
  • Unique opportunity to integrate with a multitude of manufacturers and seek new market opportunities by demonstrating an insight into this evolving industry.


Attending this conference will enable you to:

  • Understand the current market dynamics of the biotech, pharma, and biopharma industries
  • Learn how to develop strategies for biosimilars design and development for chronic disease management
  • Hear the latest trends with an overview of the year and projections for the biotech and pharmaceutical industries
  • Discuss innovations and technological developments of biosimilars as novel drug modalities for chronic disease management
  • Access different ideas and perspectives from a multitude of experts and allied industries combining regional experiences


Who should attend?

This event aims at leading biotech, biopharma, pharmaceutical companies, and government and policy think tanks seeking to learn more about developing biosimilars that can improve access to therapeutic interventions and reduce healthcare costs. Core attendees include CEOs, COOs, CFOs, Presidents, Vice Presidents, Directors, Heads of, Superintendents, Managers, and Stakeholders involved in:


Biosimilars Research

Biosimilars Delivery Platforms

Clinical Trials and Approvals

Biosimilars Drug Development

Biological Engineering of Biologics

Immunization Research & Development

Biosimilars Manufacturing


Manufacturing Research & Innovation

Biologics Technologies

Cell Lines Development

Research and Development

Genetic Engineering

Clinical Research and Development

Strategy, Projects, & Public Affairs

Biotechnology Research

Cost Reduction Strategies

Legal and Compliance Work

Modalities Research

Sales and Marketing Initiatives

Equipment Certification Services

Translational Research

Business Development

News Reporting and Journalism


From the following industries and companies:

Biotechnology Companies

Biosimilars Companies

Associations and Alliances

Pharmaceutical Companies

Generic Drugs Companies

Universities and Academia

Biosimilars Industries

Medical Technology Companies

Research and Development

Biologics Industries

Cosmetic Companies

Government Agencies

Drug Development Companies

Clinical Research Organisations

Consultants and Advisors

Drug Discovery Companies

Biological Engineering Companies

Public Consultation Groups

Formulation Companies

Global Healthcare Institutions

Legal and Compliance Services

Public Healthcare Providers

International Quality Standards

News Reporters and Journalists


Book now
To secure your place at The Biosimilars & Biologics Summit 2023 or if you require more information, please contact delegates@iQ-Hub.com

Get In Touch

Subscribe for updates:

Back to Top